Introduction
Screening donors for rare antigen constellations was one of the first applications of molecular methods to donor typing and has initially been realized with surprisingly simple methods: PCR with restriction enzyme digestion (PCR-RFLP) and PCR with sequence-specific priming (PCR-SSP) followed by agarose or acrylamide electrophoresis are standard PCR methods established in many laboratories. Since several commercial kits for molecular blood group determination are based on these methods, they are routinely used in many laboratories involved in molecular blood group determination. Both methods are primarily devised for lowthroughput analysis of a few samples but may be adapted to allow a mid-throughput use involving several hundreds to thousands of donors. Examples for such mid-throughput use include Dombrock typing of donors by PCR-RFLP and screening for donors with rare phenotypes by PCR-SSP. In this review, advantages and disadvantages of these methods are discussed and compared to other methods of molecular donor typing.
Usually all steps are performed separately. The optimal salt concentration for most restriction enzymes is higher than that used for Taq polymerase, therefore a separate cleaning step for the PCR amplicons is generally not necessary. Instead, an aliquot of the PCR product is directly added to the restriction enzyme mix.
Design Considerations
The crucial point for the development of PCR-RFLP systems is the necessity to find a suitable restriction enzyme. In the vast majority of applications, type II restriction enzymes cutting in or immediately adjacent to their recognition sequence are used. Most of these recognition sequences are 4 to 8 bp palindromic sequence motifs such as GAATTC for EcoRI. The polymorphism to detect must be located in the recognition sequence, and it must be present in one allele and absent in the other allele. Despite the high number of known restriction enzymes, many polymorphisms are not located within such a recognition site and therefore cannot be detected by 'typical' PCR-RFLP. While an artificial restriction site may be introduced in such cases by a PCR primer partly encompassing the recognition sequence, one advantage of PCR-RFLP, the simplicity of PCR primer design, is lost in such a situation.
The PCR primer design in PCR-RFLP is very easy: There are virtually no constraints on the exact primer position. Therefore, PCR primers may be chosen as suggested by primer design programs, avoiding complications stemming from unsuitable primer GC content, primer dimers, hairpin formation, or primer complementarity. The position of the restriction sites can be deduced directly from the sequence. The only constraints for primer selection are that i) PCR amplification should be specific for the gene, ii) the amplified DNA sequence must include the restriction site of interest, and iii) the informative cut or non-cut fragment must be easily distinguishable in the gel.
Often, the PCR amplicon is devised in a way that it contains at least one additional cleaving site for the same enzyme. By this way, incomplete digestion of the PCR product leads to fragments not present in completely digested PCR products of both alleles and is easily recognized. However, the PCR products should not contain too many restriction sites because it is difficult to identify the informative fragment in a complex mixture.
The size of the PCR product is usually suggested by the specific application and the type of electrophoresis. 'Normal' agarose gels are suitable to identify fragments in the range of 100 to 4,000 bp; however, it is hard to differentiate fragments with less than 10% size difference. Polyacrylamide gels can differentiate minor size differences and identify smaller products but imply a more difficult handling. Restriction enzymes with a 4 bp recognition sequence are usually 'frequent cutters' and need smaller PCR products than restriction enzymes with 6 or more bp recognition sequences. Very big PCR amplicons may be necessary if a specific amplification is combined with the RFLP digestion. For example, in a standard assay for the Rhesus box, a PCR amplicon of about 3,000 bp spanning the whole 'identity region' is amplified, because the diagnostic scenario consists of the two sequence motifs located in cis and more than 1,400 bp apart from one another.
Advantages of the Method
PCR-RFLP is one of the most immediately plausible ways to determine a genotype by PCR and was used soon after the development of the PCR technique [2] . Once a suitable restriction site is identified, development of the PCR-RFLP is very straightforward. Since there are virtually no constrains on PCR primer position, it is almost always possible to devise a stable, robust PCR reaction. Likewise, restriction enzyme digestion is a very robust step for most enzymes. Hence, PCR-RFLP is a method that usually works immediately from the start, without the need of time-consuming optimization steps. Often, PCR-RFLP is used to confirm the presence of a mutation detected by sequencing, and these systems may be used for routine allele determination later on.
Disadvantages of the Method
The choice of the restriction enzyme is largely determined by the polymorphism investigated. This is no problem as long as a single polymorphism is investigated, but a hindrance for the detection of more than one polymorphism in parallel, e.g. alleles of different blood group systems. The detection of different alleles may necessitate the use of different restriction enzymes which may trigger different incubation conditions. While parallel, modular detection may be devised with some difficulties, multiplex detection becomes very difficult as soon as more than one enzyme is necessary. Therefore, PCR-RFLP is much less amenable to the screening for a bunch of alleles than PCR-SSP, and typical multiplex applications are confined to the use of a single enzyme [3] .
Another problem of PCR-RFLP is the necessity to deal with restriction enzymes which are often less stable than the heat-stable polymerase used for the PCR reaction. This may be the reason that there are few commercial kits based on PCR-RFLP.
Possible Pitfalls
Incomplete digestion will mimic the presence of the noncleavable allele. Such incomplete digestion must be excluded by suitable controls. The optimal control is an additional cleaving site for the same enzyme in the amplicon. If such internal control is not possible, reactions with samples known to carry the different possible allele combinations AA, AB and BB should be run in parallel.
Furthermore, it must be realized that any mutation in the restriction site may prevent the restriction enzyme digestion. These alleles will behave like the 'non-digestible' allele, even if the amino acid sequence is different. For example, the K2 (K-k+) allele may be distinguished from the K1 (K+ k-) allele by the absence of a BsmI recognition sequence GAATCN (K2: GAACGC; K1: GAATGC). However, there are two K+ weak, k-variant alleles with the sequences GAAGGC and GATTGC. Both alleles do not contain the BsmI-site and are therefore not digested by BsmI, mimicking the K-k+ allele, while they actually encode a K+ weak k-phenotype [4] .
Another pitfall is the presence of an unrelated mutation in the primer binding site. Since usually primers with strong binding are chosen, PCR-RFLP is rather robust to this type of error.
Finally, as any method testing only specific mutations, additional mutations in parts of the DNA sequence not investigated may lead to wrong predictions. Typically, the presence of an antigen is predicted that is not expressed because of an unrelated mutation leading to a null allele.
Mid-Throughput Applications
Despite its focus on versatile testing of a small number of samples, PCR-RFLP was the first blood group PCR method used to predict the phenotype of red blood cell antigens in a larger number of blood donors: PCR-RFLP was used to type donors for Dombrock antigens.
Dombrock is a blood group system notoriously difficult to cope with by serological methods. Antibodies to Dombrock antigens may be clinically relevant and can cause transfusion reactions, but they may be missed even in the indirect antiglobulin technique. Furthermore, these antibodies usually occur as additional specificities in antibody mixtures produced by multi-immunized patients and tend to deteriorate during storage. Therefore, commercial Dombrock antibodies are not available, and serologic donor typing was almost impossible. Selection of components often had to be based on cross-matches. A molecular screening method was a major step ahead.
The Dombrock blood group system is based on polymorphisms of the ADP-ribosyltransferase 4 (ART4) gene. DOB encoding the Do b antigen differs from DOA encoding the Do a antigen by 378 C>T, 624 T>C, and793 A>G substitutions [5] . The first two are silent, whereas 793 A>G encodes an Asp to Asn substitution. Due to the substitution, the DOB but not the DOA allele contains a BseRI restriction site at nucleotide position 793. As an internal control, Storry et al. [6] introduced an additional BseRI cleavage site into one of the primers. Thus, the PCR product was 368 bp and split into two fragments of 326 bp and 42 bp in DOA, while DOB yielded 268, 58, and 42 bp fragments. The difference between the 326 bp and 268 bp fragments was clearly visible on 8% polyacrylamide or 4% MetaPhor agarose gels. These authors tested 613 blood donors selected for specific phenotypes and identified 91 Do b -and 303 Do a -donors. Typing for a single polymorphism does imply the risk of false-positive antigen predictions in carriers of null alleles; but such type of error is of minor importance for blood donor screening. Even if a few antigen-negative donors may have been missed, a sufficient number of suitable donors were identified. The PCR-RFLP method to determine the Do antigen status was a major step ahead, for the first time allowing an almost unlimited supply of Do-typed donors.
PCR with Sequence-Specific Priming
Principles of the Method PCR with sequence-specific priming consists of the following steps [1] : -DNA isolation -PCR amplification using allele-specific primers -Gel electrophoresis to determine the presence or absence of the allele specific PCR product. Usually all steps are performed separately. Often, the PCR mixture is designed in a way that PCR products may be directly added to the gel
Design Considerations
The crucial point of PCR-SSP is the necessity to design primers that amplify one allele and do not amplify the other allele. Usually, a primer is used the 3' end of which is exactly located at the polymorphism. Therefore, the most 3' base of this primer is mismatched to the allele that shall not be detected, and this mismatch prevents extension of the primer and, therefore, production of a PCR product. If this mechanism is used, the PCR enzyme must be non-proof-reading.
In reality, most mismatches do not totally prevent amplification, even if a non-proof-reading enzyme is used. The allele-specific detection reaction is usually multiplexed with a control reaction which has two functions: i) an inhibited PCR reaction is detected by the absence of the control PCR product, and ii) the control PCR utilizes dNTPs, slightly inhibiting the detection PCR. This inhibiting effect usually improves the specificity of the detection reaction because low-efficiency amplification of the 'wrong' allele occurs too late to produce a strong signal. Still, the design of a specific primer may be tricky. In contrast to PCR-RFLP, the primer must be positioned exactly at the site of the polymorphism, which may be a region unsuitable for primer design. Therefore, such primers often involve additional mismatches to prevent hairpin formation or to increase the binding difference between the alleles to suppress co-amplification of the 'wrong' allele.
Advantages of the Method
PCR-SSP is much more universal than PCR-RFLP. There is no need for a specific sequence motif to be present, and with knowledge in the field it is possible to devise specific primers for almost any single nucleotide polymorphism. Usually, primers may be devised in a way that allows the use of these primers with a predefined amplification scheme. Therefore, PCR-SSP may easily be used for parallel, modular detection of several alleles. It is also possible to multiplex several reactions into a single mix; there are examples of up to 6 blood group detection reactions multiplexed into a single tube.
Most commercial and many self-developed blood group PCR systems devised for low-throughput applications are based on PCR-SSP [7, 8] .
Disadvantages of the Method PCR-SSP is more difficult to develop than PCR-RFLP. Its design usually involves optimization steps, and the concentration of the specific and non-specific primers remains crucial for its sensitivity and specificity. The system is less robust than PCR-RFLP, and minimal co-amplification of the wrong allele must not be misinterpreted as positive signal.
The PCR-SSP technique requires more expertise than PCR-RFLP. Inexperienced users may be faced with a relevant rate of false-positive results [7] .
Pitfalls
As outlined above, PCR-SSP reactions need some care, and low-quality PCR reactions may lead to erroneous interpretation.
Mutations in the primer binding site not related to the mutation that shall be detected tend to prevent correct primer binding and amplification of the DNA. Since the primers are devised in a way that the mismatch to be detected leads to a stop of amplification, sequence-specific primers are usually more prone to this effect than the stably binding primers used for PCR-RFLP.
Mid-Throughput Applications
Although typical PCR-SSP with gel electrophoresis is an application devised for the investigation of a few samples, it may be adapted to mid-throughput uses. One application of these systems was screening of donors for rare antigen constellations.
In 2003, an observational study on the transfusion support for patients with antibodies to red blood cell antigens of high frequency was published [9] . It revealed that there were relevant deviations from the normal standard of transfusion medicine care in 30% of patients. Most frequently, operations were performed without sufficient compatible red blood cell units as backup. In addition, initially scheduled transfusions were reduced or abolished, and a planned invasive procedure was cancelled because no compatible units were available. Only four antibody specifities, anti-Kp b , anti-Vel, anti-Lu b and anti-Yt a , accounted for two thirds of all patients and for three fourths of patients in whom substandard transfusion support was observed.
Units negative for these antigens have a frequency ranging from 1:300 (anti-Yt a ) to 1:10,000 (anti-Kp b ). Hence, it is futile to start searching such units among non-typed units, once there is an urgent need for them. Rather, it is necessary to identify donors negative for these antigens in advance. Regrettably, serologic screening for these antigens is a pain: available antibodies are scarce, are often of low quality, and for some specificities like anti-Yt a , commercial reagents are lacking altogether. Systematic serologic typing was therefore confined to small series or based on the lucky availability of a high-quality antiserum in a blood service. Three of these specificities, Kp ; therefore, no specific product is obtained in the majority of donors. Donors lacking the allele of high frequency as well as donors heterozygous for this allele are identified by the presence of a specific product. In a second step, the exact allele status of these donors is tested in a separate, modular PCR-SSP reaction or investigated by serology. This approach has the advantage that in the first multiplex PCR reaction, it is extremely unlikely that more than one specific product has to appear and competition of the different multiplexed PCR reactions may be dismissed. In addition, donors carrying a null allele in addition to the rare allele, like Kp a /Kp-donors, will be identified by the serologic testing of the donors. However, the cumulative frequency of all 'rare' alleles included in this assay is about 20%, and a considerable amount of follow-up testing is to be expected. A variation of this kit includes PCR reactions for D and may be useful to identify D-donors with rare antigen constellations.
We devised a different PCR-SSP application [10] based on direct multiplex detection of the frequent alleles COA, LUB, KPB, and YTA. In this approach, donors negative for one polymorphism could be easily detected by the absence of one of four PCR amplicons. Since almost any individual on earth will be positive for at least one of these alleles, a non-specific control band was not included in the PCR set-up.
This application used the very simple 'Extract-N-Amp' ® DNA isolation method. In place of a normal DNA isolation, a crude DNA extract was produced by a simple two-step method. Without automation, DNA of 91 donors could be prepared in 21-24 min, which is comparable to automated DNA isolation. The whole procedure starting with collected tubes took about 200 min for 91 donors including 102 min of hands-on time. Cost of consumables and reagents were about EUR 1.50 for 4 predicted antigens, which was comparable to standard serologic techniques and much lower than more advanced PCR techniques. Of the hands-on time, 46 min were related to the agarose gels because three gels were used for 91 donors. This time could be even more reduced if gels with more lanes were used. Usually, the method was used in batches of 91 donors, which seems few compared to the batch sizes of some highthroughput methods. However, we found that this number is sufficient for many applications: the method was mainly used to screen O ccddee K-second-time donors. donors correspond to about 1,500 non-selected donors. Since each donor has to be tested only a single time, most blood services will not even need daily testing to fulfil their needs as long as testing is restricted to specific donor groups.
While this method was successfully used in our institute to type more than 3,000 donors and led to the identification of 10 Yt -donors, a drawback of this approach was a high rate of inconclusive results: 10-20% of reactions had to be repeated. This high repeat rate was probably due to the simplified DNA isolation method. We stick with this method, however, because a change to a more conventional DNA isolation method likely incurs more workload than the repetition of 15% of samples.
Another limitation of this method was the need to confirm the phenotype by serology because a single SNP prediction was considered insufficient for a high-accuracy phenotype prediction. The serological confirmation did not pose much additional workload because it was only necessary for the rare, probably antigen-negative donors.
Conclusion
Manual methods like PCR-RFLP or PCR-SSP with agarose gel electrophoresis may be used in mid-throughput settings to identify donors with rare antigen constellations or antigen constellations that cannot be determined by serology. If testing is focused on specific donor groups, like donors compatible to the needs of , Yt a typing, testing up to 90 donors per day is more than sufficient even for large blood services.
The main advantage of manual methods compared to more advanced methods is the quick implementation and the abdication of special equipment. Therefore, manual molecular testing may be a good choice for blood services that want to mine the advantages of molecular blood group determination without investing too much.
Two major limitations of manual methods are the limited number of polymorphisms investigated and the data transfer. Considering the number of polymorphisms, the PCR-RFLP method presented tested just one polymorphism and the PCR-SSP methods 4-6 polymorphisms. State-of-the-art highthroughput methods allow the determination of up to 100 polymorphisms and vastly outperform manual methods in this respect. The data transfer in our PCR-SSP methods was limited to the rare donors negative for high-frequency antigens. Manual data interpretation and data transfer of results would have been very difficult if this assay would have been extended to typing of other polymorphic antigens like Fy or Jk.
Pooled PCR assays may be used in manual methods to increase throughput, as long as the positive event is rare, like RHD+ DEL donors missed by serology among seemingly D-donors. If the focus is on donors negative for antigens of high prevalence, a possible approach is a pooled PCR testing for the rare alternative allele: For example, a screen for Kp bdonors could start with identifying Kp a + donors in a pooled PCR assay.
Considering these limitations, it is not surprising that the laboratories who developed these methods moved on to more advanced settings: the Do antigens are nowadays included in the beadchip system [11] , and the Co a , Kp b , Lu b , Yt a antigens have been taken from agarose gel to capillary electrophoresis and expanded to include Fy, Jk, MN, and Ss antigens and to use pooled analysis of PCR fragments [12] .
